Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.1123 EUR
1.85 M EUR
13.08 M EUR
4.75 M
About BIOHIT OYJ B
Sector
Industry
CEO
Jussi Hahtela
Website
Headquarters
Helsinki
Founded
1988
ISIN
FI0009005482
FIGI
Biohit Oyj engages in the development, manufacture, and market of diagnostic tests and analysis systems. It also offers acetaldehyde binding products, monoclonal antibodies, and instruments. The company was founded by Osmo Suovaniemi in 1988 and is headquartered in Helsinki, Finland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on LS exchange Biohit Oyj Class B stocks are traded under the ticker 926123.
We've gathered analysts' opinions on Biohit Oyj Class B future price: according to them, 926123 price has a max estimate of 2.70 EUR and a min estimate of 2.70 EUR. Watch 926123 chart and read a more detailed Biohit Oyj Class B stock forecast: see what analysts think of Biohit Oyj Class B and suggest that you do with its stocks.
Yes, you can track Biohit Oyj Class B financials in yearly and quarterly reports right on TradingView.
Biohit Oyj Class B is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
926123 earnings for the last half-year are 0.08 EUR per share, whereas the estimation was 0.09 EUR, resulting in a −8.10% surprise. The estimated earnings for the next half-year are 0.04 EUR per share. See more details about Biohit Oyj Class B earnings.
Biohit Oyj Class B revenue for the last half-year amounts to 7.43 M EUR, despite the estimated figure of 7.60 M EUR. In the next half-year revenue is expected to reach 7.69 M EUR.
926123 net income for the last half-year is 1.20 M EUR, while the previous report showed 500.00 K EUR of net income which accounts for 140.00% change. Track more Biohit Oyj Class B financial stats to get the full picture.
No, 926123 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 12, 2024, the company has 46.00 employees. See our rating of the largest employees — is Biohit Oyj Class B on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Biohit Oyj Class B EBITDA is 2.10 M EUR, and current EBITDA margin is 16.86%. See more stats in Biohit Oyj Class B financial statements.
Like other stocks, 926123 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Biohit Oyj Class B stock right from TradingView charts — choose your broker and connect to your account.